Overcoming therapeutic MAb resistance in agressive HER2 positive breast carcinomas by adoptive immunotherapy using optizimed effectors cells
- Resource Type
- Journal
- Source
CANCER IMMUNOLOGY RESEARCH ; OCT 2015, 3 10, 2p. Supplement: S- Subject
- Language
- English
- ISSN
- 23266074